Rajabiun, Serena
Heath, Corliss
Walter, Angela Wangari
Scott, Judith C.
Downes, Alicia
Jennings, Esther
Cabral, Howard J.
Flores-Rodriguez, Cecilia
Sprague Martinez, Linda
Funding for this research was provided by:
Health Resources and Services Administration (#U90HA39727, #U90HA39727, #U90HA39727, #U90HA39727, #U90HA39727, #U90HA39727, #U90HA39727, #U90HA39727)
Article History
Received: 23 November 2022
Accepted: 25 April 2023
First Online: 26 May 2023
Declarations
:
: This study protocol was approved by the Institutional Review Boards for the Evaluation and Technical Assistance Provider at the University of Massachusetts, Lowell (UML), Boston University Charles River Campus (BU) and Boston University Medical Campus (BUMC) (H-41438) and the local Institutional Review Boards of the 12 participating study sites in accordance to their respective guidelines. All human subjects research is performed in accordance with the guidelines and regulations as set forth in the Declaration of Helsinki and in accordance with the guidelines of the Institutional Reviews Boards for UML/BU/BUMC and the 12 participating study sites. Informed consent is obtained from all participants for this study. TableĀ 4 lists the 12 study sites, their local IRB and the approval numbers.
: Not applicable.
: The authors declare that they have no competing interests.